Pharsight

Drugs that contain Abemaciclib

1. Verzenio patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7855211 ELI LILLY AND CO Protein kinase inhibitors
Dec, 2029

(5 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Oct 12, 2024
New Indication(I-877) Oct 12, 2024
New Chemical Entity Exclusivity(NCE) Sep 28, 2022
New Indication(I-768) Feb 26, 2021

NCE-1 date: 28 September, 2021

Market Authorisation Date: 28 September, 2017

Treatment: In combination with fulvestrant for the treatment of adult patients with hr-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer with disease progres...

Dosage: TABLET;ORAL

More Information on Dosage

VERZENIO family patents

Family Patents